Enzo Biochem

These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. The Company operates through three segments: Enzo Life Sciences, Enzo Clinical Labs and Enzo Therapeutics. Enzo Life Sciences segment manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers around the world. Enzo Clinical Labs segment provides diagnostic services to the healthcare community. Enzo Therapeutics segment conducts research and development activities for therapeutic drug candidates.
New York, US
Size (employees)
443 (est)
Enzo Biochem was founded in 1976 and is headquartered in New York, US

Enzo Biochem Office Locations

Enzo Biochem has office in New York
New York, US

Enzo Biochem Metrics

Enzo Biochem Summary

Market capitalization

$307 M

Closing share price

Enzo Biochem's current market capitalization is $307 M.

Enzo Biochem Market Value History

Enzo Biochem Company Life

You may also be interested in